Case report of exposure to voriconazole in the second and third trimesters of pregnancy.

Shoai Tehrani, M; Sicre de Fontbrune, F; Roth, P; Allisy, C; Bougnoux, M-E; Hermine, O; Lecuit, M; Lortholary, O; Charlier, C

Shoai Tehrani, M; Sicre de Fontbrune, F; Roth, P; Allisy, C; Bougnoux, M-E; Hermine, O; Lecuit, M; Lortholary, O; Charlier, C.

Antimicrob Agents Chemother ; 57(2): 1094-5, 2013 Feb.

Article in En | MEDLINE | ID: mdl-23165463

Subject(s)

Aspergillosis/drug therapy; Pyrimidines/adverse effects; Pyrimidines/therapeutic use; Triazoles/adverse effects; Triazoles/therapeutic use; Adult; Aspergillus flavus/drug effects; Aspergillus flavus/isolation & purification; Female; Humans; Pregnancy; Pregnancy Trimester, Third; Pyrimidines/pharmacology; Triazoles/pharmacology; Voriconazole

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Aspergillosis / Triazoles Limits: Adult / Female / Humans / Pregnancy Language: En Journal: Antimicrob Agents Chemother Year: 2013 Type: Article

Fulltext

XML

PubMed Links

Search on Google